Author: Georgiana Murariu

Diabetes Prevention & Management – a Perspective From UK HCPs

The summer of 2015 has been an unusually eventful one in the therapeutic area of diabetes, with Diabetes UK warning that a large proportion of the fiscal difficulties currently faced by the NHS can be attributed to a sharp rise in diabetes cases in the country. Rising from 2.1 million in 2005 to 3.3 million in 2015, the number of cases has increased by a whopping 60% while diabetes treatments such as insulin and metformin account for 10% of the total NHS drug bill. In the meantime, recent reports have estimated that around one in three adults in the...

Read More

Social Media Study Shows Why HCPs are Opposed to #NHS 7 Day Access Initiative

One of the first in a series of post-election health reform oriented announcements, Jeremy Hunt recently announced plans to make GP surgeries accessible 7 days a week, calling the initiative a ‘new deal’ for GPs, whereby in return for the extended opening hours, surgeries would receive financial investment in the areas of technology and innovation. The prospect of a 7 day GP surgery would be fairly novel within Europe, as presently many countries operate under an out-of-hours emergency primary care system, which means one is able to make an appointment at the weekend if their condition is deemed urgent...

Read More

How does Lucentis/Avastin debate affect Roche’s reputation among doctors?

Background Studies that confirmed Avastin’s equivalence to Lucentis in treating age-related macular degeneration have been in the public eye since 2012. Recently however, there has been a resurgence in news around the topic, with organisations such as WHO and the British Medical Journal contributing to the conversation. Avastin and Lucentis are both medications manufactured by Roche, but in Europe only the latter is licensed to treat age-related macular degeneration (or AMD for short). The condition is currently the leading cause of blindness in developed countries. In an interview to BBC’s Mark Porter, James Cave of the Drug & Therapeutics...

Read More

Vaccines: Global HCP conversations illustrate public health priorities worldwide

With the recent measles outbreak causing widespread alarm in the US, approaches and attitudes to vaccination have seen a new peak in terms of public conversation over recent weeks. With some parents citing personal beliefs and the fear of the potential side effects of vaccinating their children, the topic has been elevated to global proportions by celebrities who have used their fame as a platform to protest vaccination. Other times, the discussion around the practice of vaccination has veered into political territory, becoming a sort of proxy for bigger structural issues within the healthcare system. Already having some idea...

Read More

Social media study reveals UK pharmacists’ most pressing issues

We have known for a while now that factors such as a rapidly ageing population and rapidly changing patient expectations are contributing to gaps in NHS funding. The intersection of advances in technology, the need to be financially efficient, and the need for positive health outcomes to be put forward has significantly altered both treatment and decision-making processes within the NHS. A new study, conducted by Creation Healthcare, focuses on one particular type of healthcare professionals to analyse what topics and aspects of the healthcare system really matter to pharmacists in the UK– a group whose conversations may hold...

Read More

Twitter

Upcoming Events

Categories

The HCP insights eJournal for leaders in healthcare  Subscribe